Aberdeen Sells Nearly 3,000 Shares of Biotech Giant Amgen

Aberdeen Wealth Management LLC has reduced its stake in Amgen Inc. by 64.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission.

The fund owned 1,542 shares of Amgen's stock after selling 2,807 shares during the period. These holdings were worth $558,000 as of its most recent SEC filing.

Aberdeen Wealth Management LLC is not alone in changing its position in Amgen. Other institutional investors and hedge funds have also made adjustments to their stakes in AMGN this quarter.